Table 2.

Daily nutrient intake assessed by the web-FFQ stratified by prostate cancer progression status

Daily intakeTotal (n = 46)Nonprogression (n = 34)Progression (n = 12)Pa
Energy (kcal)0.28
 Mean ± SD2,585 ± 9002,519 ± 8752,772 ± 983
 Median (IQR)2,490 (1,871–2,970)2,444 (1,834–2,854)2,533 (2,206–3,131)
Protein (g)0.63
 Mean ± SD102.0 ± 40.6102.0 ± 44.4101.8 ± 28.8
 Median (IQR)95.5 (71.2–116.8)94.3 (68.8–117.4)98.3 (89.1–121.5)
Total fat (g)0.36
 Mean ± SD97.8 ± 38.795.9 ± 40.7103.4 ± 33.3
 Median (IQR)87.5 (72.0–117.1)85.6 (65.4–113.8)100.0 (78.4–122.6)
Total ω-3 (g)0.69
 Mean ± SD2.25 ± 0.982.26 ± 1.072.23 ± 0.73
 Median (IQR)2.09 (1.57–2.92)2.09 (1.53–2.92)2.15 (1.74–2.71)
 ALA (g)0.53
  Mean ± SD1.81 ± 0.761.77 ± 0.761.91 ± 0.77
  Median (IQR)1.70 (1.28–2.26)1.66 (1.27–2.12)1.78 (1.34–2.38)
 LC ω-3 (g)0.23
  Mean ± SD0.44 ± 0.410.48 ± 0.440.32 ± 0.26
  Median (IQR)0.32 (0.21–0.59)0.36 (0.21–0.67)0.24 (0.12–0.43)
 EPA (g)0.26
  Mean ± SD0.14 ± 0.130.15 ± 0.140.10 ± 0.08
  Median (IQR)0.11 (0.06–0.20)0.12 (0.07–0.21)0.08 (0.04–0.15)
 DPA (g)0.21
  Mean ± SD0.05 ± 0.050.06 ± 0.050.04 ± 0.03
  Median (IQR)0.04 (0.02–0.06)0.04 (0.02–0.07)0.03 (0.02–0.05)
 DHA (g)0.23
  Mean ± SD0.25 ± 0.240.27 ± 0.260.18 ± 0.15
  Median (IQR)0.17 (0.11–0.32)0.21 (0.12–0.39)0.13 (0.07–0.24)
Total ω-6 (g)0.17
 Mean ± SD15.29 ± 5.6914.55 ± 5.5117.40 ± 5.91
 Median (IQR)14.12 (10.62–19.59)13.25 (10.18–18.64)17.28 (11.57–22.51)
ω-6/ω-3 ratio0.08
 Mean ± SD7.26 ± 2.147.01 ± 2.257.95 ± 1.70
 Median (IQR)6.93 (5.97–8.49)6.86 (5.54–8.34)8.07 (6.40–9.45)

NOTE: Prostate cancer progression is defined as biopsy-detected Gleason 7 at the first repeat biopsy session.

Abbreviation: LC ω-3, long chain omega-3 fatty acids (EPA+DPA+DHA).

  • aP values were obtained by using the Fligner-Policello test.